Endocrine and metabolic testing manual,4th ed

Thyroid Gland Testing; Thyroid Hormone Reserve; Thyroid Hormone Excess; Thyroid Malignancies; Pituitary Gland Testing; Corticotroph (Adrenocorticotropic Hormone) Reserve; Corticotroph (Adrenocorticotropic Hormone) Excess; Somatotroph (Growth Hormone) Reserve 65; Somatotroph (Growth Hormone) Excess; Gonadotroph Reserve; Gonadotroph Excess; Thyrotropin (Thyroid-Stimulating Hormone) Reserve; Thyrotropin (Thyroid-Stimulating Hormone) Excess; Prolactotroph (Prolactin) Reserve; Prolactotroph (Prolactin) Excess; Posterior Pituitary Arginine Vasopressin Reserve; Posterior Pituitary (Arginine Vasopressin) Excess; Detection of the Leakage of Cerebrospinal Fluid (CSF); in Pituitary Disease or after Transsphenoidal Surgery; Pancreas Gland Testing (Hypoglycemia and Diabetes); Tests for Nonfasting or Random Hypoglycemia and Fasting Hypoglycemia; Tests for Fasting Hypoglycemia in Adult Patients; Tests for Hypoglycemia in Pediatric Patients; Insulin Reserve; Diabetes Mellitus: Diagnosis and Control of Hyperglycemia; Criteria for Identification of Insulin Resistance or Early Diabetes Mellitus; Risk Assessment for Complications of Diabetes Mellitus; Nonlipid Markers of Cardiovascular Disease; Lipid Markers of Cardiovascular Disease; Apolipoprotein (ApoB, ApoC, ApoE, and Lp(a)) Testing; in Disorders of Lipid Metabolism; Tests for Complications of Hyperglycemia; Retinopathy of Diabetes Mellitus; Nephropathy of Diabetes Mellitus (DM); Neuropathy of Diabetes Mellitus; Ketoacidopathy of Diabetes Mellitus; Hepatopathy as a Complication of Diabetes Mellitus; Adrenal Gland; Glucocorticoid Reserve; Glucocorticoid Excess in Cushing's Syndrome; Determining the Etiology of Cushing's Syndrome; Mineralocorticoid Reserve; Mineralocorticoid Excess; Catecholamine Excess (Pheochromocytoma); Virilizing Gonadal Steroids of Adrenal Origin in Females; Bone and Parathyroid Glands; Assessment of the Axial Skeleton (Spine and Hip); Bone Turnover Assessment; Calcium Metabolism Assessment; Parathyroid Adenoma Localization; Discriminating Between Osteoporosis and Osteomalacia; Male Reproductive Organ and Sexual Differentiation Testing; Testes; Male Infertility; Neoplasms of the Male Reproductive Tract; Sex Differentiation; Female Reproductive Organ Testing; Ovaries, Uterus, and Placenta 397; Female Infertility, the Menopause Transition, and the Polycystic Ovary Syndrome; Pregnancy; Female Androgens; Neoplasms of the Female Reproductive Tract; Gastroenteropancreatic (Noninsulinoma) Endocrine Tumors and Endocrine Tissue Tumor Markers; Gastrinomas; Carcinoid Tumors; Other Hormone-Producing Gastrointestinal Tumors; Gastroenteropancreatic Tumor Imaging; Tumor Markers Secreted from Endocrine Tissue; Tests for Nutritional Status; Body Composition Analysis and Nutritional Assessment; Nutritional Status as Marked by Levels of Vitamins, Minerals, and Other Nutrients; Diagnosis of Eating Disorders and Nutrition-Related Diseases; Emerging or Historical Endocrine and Metabolic Tests with Potential Clinical Utility; Tests for Thyroid Disorders; Tests for Pituitary Tumors; Tests for Hypoglycemia and Hyperglycemia; Tests for Markers of Cardiovascular Disease in Diabetes Mellitus Patients; Tests for Hyperglycemic Complications of Diabetes Mellitus; Tests for Determining Adrenal Status; Test for Bone Density in the Peripheral Skeleton; Male Reproductive System Test; Female Reproductive System Tests; Endocrine Tumor Test; Appendix 1: Questionnaires; Appendix 2: Specimen Collection Protocols; SCP-1: Urine Sample Collection: Patient Instructions; SCP-2: Saliva Sample Collection: Patient Instructions; SCP-3: Semen Sample Collection: Patient Instructions; SCP-4: Blood Sample Collection Protocol: Growth Hormone (GH) Testing; SCP-5: Blood Sample Collection Protocol: Bilateral Inferior Petrosal Sinus Sampling; SCP-6: Blood Sample Collection Protocol: Measurement; of Potassium [K+] in Nonhemolyzed Blood; SCP-7: Blood Sample Collection Protocol and Report Form: Adrenal Vein Sampling; SCP-8: Blood Sample Collection Protocol: Selective Venous Sampling; for Localization of Hyperfunctioning Parathyroid Glands; SCP-9: Blood Sample Collection Protocol: Measurement of Testosterone in Blood